GenXys Health Care Systems

07/11/2023

As technology progresses quickly, GenXys has its finger on the pulse of all changes.

New guidelines for clinical genotyping, focused on expanding previous guidelines for TMPT, NUDT15, CYP2C19, CYP2C9, and CYP2D6 genes, as well as those related to warfarin testing. These updates were recently published in the Journal of Molecular Diagnostics and should be implemented alongside existing clinical guidelines from organizations like CPIC and DPWG, which provide guidance on interpreting pharmacogenomic (PGx) test results and making therapeutic recommendations for specific drug-gene interactions. The AMP Pharmacogenetics Working Group highlighted relevant genes, variants, and candidates for pharmacogenetics (PGx) testing, which you can read more about at the link below.

GenXys is always staying up to date with industry changes and novel findings, which we directly implement into our clinical decision support software so that our clients are always making choices based on up-to-date and clinically relevant information and guidelines.

Read the full publication here: https://hubs.ly/Q01XmqzW0

The AMP Pharmacogenetics Working Group recommended four alleles for a minimum panel (tier 1) and one allele for an extended panel (tier 2).

02/22/2023

What do you do when your medication is causing adverse side effects, but you are taking more than one medication?
This is a problem that more and more patients are running into, particularly older adults. One of the ways to address this is with comprehensive medication reviews (CMRs).

This article from JAMA Health Forum shows that, despite the fact that older adults are receptive to CMRs, they are not receiving them at the rate that they need.

Automated medication review software is a fantastic tool that healthcare professionals can use to make CMRs more efficient and accurate, allowing them to conduct this much-needed service more easily to close the gap between patients who wish to receive a CMR and those who actually do.

Read the whole article here: https://bit.ly/2UZV9BM

The use of prescription medications among US adults has increased over time, including the use of 5 or more medications daily (ie, polypharmacy).1 With increased medication use comes the potential for problems including drug interactions, adverse effects, persistent use of medications no longer...

01/04/2023

Precision medicine means ditching the one-size-fits-all approach to prescribing to ensure that patients receive the medication that works for them. To do this, providers look at , drug interactions, liver and kidney function, any other diseases, lab tests, and other patient data. With TreatGxplus, which is covered for eligible Green Shield Canada (GSC) plan members, patients and providers can use to get patients feeling better, faster.
To learn more, visit www.genxys.com/content/en-gsc-members/

12/28/2022

With so many options on the market today, it can be stressful for patients to find which options match their needs. That's why is introducing the Digital Clinic, where plan members can easily access the digital services that they need - including testing and counselling with GenXys - all in one place.
Access the Digital Clinic at https://www.greenshield.ca/en-ca/the-digital-clinic or read more at https://www.greenshield.ca/.../green-shield-canada...

The Digital Clinic offers a suite of products and services that allow you to access health care from your own home, your phone, or literally anywhere.

12/21/2022

This article from EHR Intelligence lays out the reasons why genomic information should live in the EHR. In particular, the author highlights the use of clinical decision support as a key reason why genomic integration is important.
We want health care practitioners to be able to use their patients’ pharmacogenetic information effectively using data from within the EHR. This way, patients might have more opportunities to benefit from having done a pharmacogenetic test. As well, clinical decision support software, like our own TreatGx and ReviewGx, are even more powerful with EHR integration.
Read the full article here: https://bit.ly/3vJSxZo

12/14/2022

Wondering how to understand and make use of your pharmacogenetic (PGx) test results? With TreatGxplus, it's easy! You'll get a simple PGx report and, with the support of GenXys' TreatGx software, you can work with your healthcare provider to get personalized and optimized medication options.
Learn about your genes and access actionable insights with TreatGxplus. To learn more about GenXys and Green Shield Canada (GSC), visit https://bit.ly/3aODlSH

12/07/2022

What an exciting way to end off the year! GenXys has been named to the 2022 Insights Digital Health Top 150!

We’re grateful for the continuous support from our hardworking team and our rapidly-growing customer base. GenXys strives to provide clinically actionable tools to increase patient safety and help solve healthcare’s most pressing challenges. By doing so, we contribute to the reduction in the number of adverse drug reactions per year.

As we enter the new year, we look forward to helping our customers build their pharmacogenetics programs and to do our part in increasing patient safety.

Thank you, CB Insights!

Check out the official press release here: https://www.genxys.com/genxys-named-to-the-2022-cb-insights-digital-health-150-list/

11/30/2022

Wondering what makes a (PGx) test different from other genetic tests? PGx looks at your to find gene variants which determine your response to medications. This could be side effects or how the medication will actually work for you. With TreatGxplus, your healthcare provider will be able to combine pharmacogenetic information with other health factors to find the medication that is safe and will work for you.
Eligible Green Shield Canada (GSC) plan members can get TreatGxplus covered. Learn more at https://www.genxys.com/content/en-gsc-members/

11/23/2022

"Almost everyone (99.5% of individuals) is likely to have an abnormal or "atypical" response to at least one therapeutic drug."
In a recently-published article, pharmacogenomics expert Professor Russ Altman shared this eye-opening statistic. PGx is no longer just a nice-to-have. It's clear that everyone can benefit from having their pharmacogenomic data considered whenever they are prescribed with medications.
Although this study was conducted on a population that largely consists of those with European ancestry, the extremely high rate of people who are likely to have atypical responses to at least one drug may indicate that rates are similarly high in those who are not of European descent. However, more researchers are extending their studies to diverse populations, as pharmacogenetics can and must benefit more people. http://stan.md/36l6vGT

11/16/2022

Did you know?
Depression is a common mental health condition that affects more than 264 million people worldwide.
What's more, between 30% and 50% of patients with the major depressive disorder do not respond to their first antidepressant trial.
Pharmacogenetics has been introduced as a method for reducing that trial and error period. In this article, our Chief Scientific Officer, Prof. Martin Dawes will discuss pharmacogenetics' role in treating depression. More specifically, he will answer the following questions:
- What can a person’s genes tell them about how they might react to antidepressants?
- How can pharmacogenetic information be integrated into prescribing decisions?
- How can pharmacogenetic information be more actionable at the point of care?
Find out more here: https://bit.ly/2XlsIRd

11/09/2022

Check out this great article by Benjamin Laker that provides four insightful recommendations on how to improve employee wellness programs. His points really hit home with us- providing employees with personalized support is critical. At GenXys, we strive to ensure that employees can find optimized treatment for them, right away, through personalized medicine. https://bit.ly/3x0sP2T
Ready to explore personalized medicine and pharmacogenetics? Here's how eligible GSC plan members can get TreatGxplus covered: https://bit.ly/3fwVG82

11/02/2022

With so many options on the market today, it can be stressful for patients to find which options match their needs. That's why is introducing the Digital Clinic, where plan members can easily access the digital services that they need - including testing and counselling with GenXys - all in one place.

Access the Digital Clinic at https://www.greenshield.ca/en-ca/the-digital-clinic or read more at https://www.greenshield.ca/.../green-shield-canada...

The Digital Clinic offers a suite of products and services that allow you to access health care from your own home, your phone, or literally anywhere.